ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,927Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 2604

$412K Total Retail Price of All Prescriptions

Rank: 360 out of 2604

341 Patients Receiving at Least One Drug in Part D
30%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

38% of this provider’s 341 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 4,565 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 794 289 1 2
LISINOPRIL 692 203 2 3
AMLODIPINE BESYLATE 560 195 3 6
ACETAMINOPHEN-CODEINE 499 165 S3 4 60
METFORMIN HCL 395 131 5 7
HYDROCHLOROTHIAZIDE 390 171 6 10
OMEPRAZOLE 354 139 7 5
PROAIR HFA 296 101 8 27
RANITIDINE HCL 284 116 9 25
METOPROLOL TARTRATE 246 126 10 9
FUROSEMIDE 239 112 11 8
LOSARTAN POTASSIUM 213 83 12 20
POTASSIUM CHLORIDE 202 100 13 16
FLUTICASONE PROPIONATE 172 49 14 31
PROMETHAZINE HCL 169 51 R 15 88
HYDROCORTISONE 161 50 16 161
CLONIDINE HCL 149 72 17 56
GABAPENTIN 146 30 18 12
ISOSORBIDE MONONITRATE ER 139 83 19 38
LANTUS 137 57 20 40
ENALAPRIL MALEATE 132 73 21 50
HYDRALAZINE HCL 131 40 22 85
SURE COMFORT ALCOHOL 124 32 23 372
LEVOTHYROXINE SODIUM 121 58 24 4
CRESTOR 120 38 25 47
EASY TOUCH 114 39 26 283
MELOXICAM 112 48 27 36
CYCLOBENZAPRINE HCL 106 18 R 28 43
ATORVASTATIN CALCIUM 103 31 29 19
IBUPROFEN 97 31 30 32
HYDROXYZINE HCL 91 0 R 31 214
AMOXICILLIN 90 24 32 99
OXYBUTYNIN CHLORIDE 84 30 33 92
QVAR 84 38 33 151
NIFEDIPINE ER 79 40 35 121
WARFARIN SODIUM 79 44 35 13
TRAMADOL HCL 77 33 37 15
CARVEDILOL 76 45 38 26
CLOPIDOGREL 73 33 39 39
NAPROXEN 71 25 40 76
DESOXIMETASONE 68 44 41 200
NOVOLOG 68 23 41 89
FENOFIBRATE 67 31 43 69
PHENYTOIN SODIUM EXTENDED 63 0 44 135
PLAVIX 56 28 45 75
SURE COMFORT 55 15 46 238
TRIAMTERENE-HCTZ 53 21 47 55
LEVETIRACETAM 53 32 47 96
SPIRONOLACTONE 52 0 49 78
MIRTAZAPINE 51 33 50 52
NIFEDIAC CC 50 29 51 294
ATENOLOL 50 39 51 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.